| 000 | 01430 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250514054317.0 | ||
| 264 | 0 | _c20030124 | |
| 008 | 200301s 0 0 eng d | ||
| 022 | _a0027-8874 | ||
| 024 | 7 |
_a10.1093/jnci/95.1.9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRandal, Judith | |
| 245 | 0 | 0 |
_aNIH workshop tries to create consensus on HRT use. _h[electronic resource] |
| 260 |
_bJournal of the National Cancer Institute _cJan 2003 |
||
| 300 |
_a9-11 p. _bdigital |
||
| 500 | _aPublication Type: News | ||
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 |
_aBreast Neoplasms _xchemically induced |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xchemically induced |
| 650 | 0 | 4 | _aConsensus Development Conferences, NIH as Topic |
| 650 | 0 | 4 |
_aCoronary Disease _xprevention & control |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 |
_aEstrogen Replacement Therapy _xadverse effects |
| 650 | 0 | 4 |
_aEstrogens, Conjugated (USP) _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMedroxyprogesterone Acetate _xadministration & dosage |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 | _aUnited Kingdom |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aUnited States Food and Drug Administration |
| 773 | 0 |
_tJournal of the National Cancer Institute _gvol. 95 _gno. 1 _gp. 9-11 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jnci/95.1.9 _zAvailable from publisher's website |
| 999 |
_c12312612 _d12312612 |
||